NCT05759195View on ClinicalTrials.gov

Biomolecular Analysis for Predicting Response to Regorafenib

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 7, 2021

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions
GlioblastomaGlioblastoma, IDH-wildtype
Interventions
DIAGNOSTIC_TEST

Biomolecular tumor analysis

NGS analysis, other molecular analyses on FFPE tumor tissue

Trial Locations (1)

00168

Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT05759195 - Biomolecular Analysis for Predicting Response to Regorafenib | Biotech Hunter | Biotech Hunter